Effect of Dimenhydrinate on Heart Rate Variability (HRV)
Phase 1
Recruiting
- Conditions
- Assessment of Cardiac autonomic system responses to oral administration of Dimenhydrinate in healthy subjects.
- Registration Number
- IRCT20230606058390N1
- Lead Sponsor
- Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Healthy subjects
Normal Body Mass Index (BMI)
19 to 26 years olds
Exclusion Criteria
Smoking
Alcohol consumption
Substance abuse
Cardiovascular diseases
Acute and chronic diseases
Prohibition of Dimenhydrinate
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The effect of Dimenhydrinate 50 mg tablets on HRV. Timepoint: Before starting the intervention and every 30 minutes after the start of taking Dimenhydrinate tablets 50 mg or placebo for 4 hours. Method of measurement: HRV recording device and eprobe software.
- Secondary Outcome Measures
Name Time Method